<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37384711</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>6</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Impact of overweight and obesity on disease activity and remission in systemic lupus erythematosus: A systematic review and meta-analysis protocol.</ArticleTitle><Pagination><StartPage>e0287753</StartPage><MedlinePgn>e0287753</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0287753</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0287753</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Systemic lupus erythematosus (SLE) is an autoimmune and inflammatory disease that requires treatment with hydroxychloroquine and glucocorticoids. Glucocorticoids are responsible for adverse effects such as increased weight, which can modify the severity and chronicity of autoimmune pathologies.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To summarize scientific evidence regarding the impact of overweight and obesity on disease activity and remission in SLE.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The protocol was developed according to the Preferred Reporting Items for Systematic Review and Meta-analysis Protocol (PRISMA-P) and published in the International Prospective Register of Systematic Reviews database (PROSPERO-CRD42021268217). PubMed, Scopus, Embase, and Google Scholar will be searched for observational studies including adult patients with SLE who were overweight and obese or not, that included disease activity or remission as outcomes. The search is planned for May 2023. Three independent authors will select the eligible articles and extract their data. Subsequently, three authors will independently extract data from each included study using an extraction form created by the researchers. Methodological quality analyses will be performed using the modified Newcastle-Ottawa scale. The results will be presented as a narrative synthesis according to the synthesis without a meta-analysis reporting guideline (SWiM). Meta-analysis will be conducted where appropriate using random-effects models.</AbstractText><AbstractText Label="EXPECTED RESULTS" NlmCategory="RESULTS">This review will identify the impact of overweight and obesity on the clinical features of SLE, helping clinicians manage disease activity and remission, both important to optimize disease outcomes and patient quality of life.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 Medeiros et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Medeiros</LastName><ForeName>Mar&#xed;lia Cristina Santos de</ForeName><Initials>MCS</Initials><AffiliationInfo><Affiliation>Postgraduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Souza</LastName><ForeName>Karla Simone Costa de</ForeName><Initials>KSC</Initials><AffiliationInfo><Affiliation>Department of Clinical and Toxicological Analyses, Federal University of Rio Grande Do Norte, Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galdino</LastName><ForeName>Ony Ara&#xfa;jo</ForeName><Initials>OA</Initials><Identifier Source="ORCID">0000-0002-5190-4638</Identifier><AffiliationInfo><Affiliation>Postgraduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cobucci</LastName><ForeName>Ricardo Ney</ForeName><Initials>RN</Initials><Identifier Source="ORCID">0000-0002-0184-2061</Identifier><AffiliationInfo><Affiliation>Graduate Program of Biotechnology, Universidade Potiguar (UnP), Natal, RN, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Sciences Applied to Women's Health, Maternidade Escola Janu&#xe1;rio Cicco (MECJ/ EBSERH), Federal University of Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Rezende</LastName><ForeName>Adriana Augusto</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0003-2452-4047</Identifier><AffiliationInfo><Affiliation>Department of Clinical and Toxicological Analyses, Federal University of Rio Grande Do Norte, Natal, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005938">Glucocorticoids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050177" MajorTopicYN="Y">Overweight</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005938" MajorTopicYN="N">Glucocorticoids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078202" MajorTopicYN="N">Systematic Reviews as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015201" MajorTopicYN="N">Meta-Analysis as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010936" MajorTopicYN="N">Plant Extracts</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012196" MajorTopicYN="N">Review Literature as Topic</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>29</Day><Hour>19</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>29</Day><Hour>14</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37384711</ArticleId><ArticleId IdType="pmc">PMC10309980</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0287753</ArticleId><ArticleId IdType="pii">PONE-D-22-22953</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fanouriakis A, Kostopoulo M, Alunno A, Aringer M, Bajema I, Boletis JN, et al.. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. 2019 Ann Rheum Dis 2019;1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">30926722</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong W, Lahita RG. Pragmatic approaches to therapy for systemic lupus erythematosus. Nat Rev Rheumatol. 2014;10(2):97&#x2013;107. doi: 10.1038/nrrheum.2013.157</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2013.157</ArticleId><ArticleId IdType="pubmed">24166241</ArticleId></ArticleIdList></Reference><Reference><Citation>Justiz Vaillant AA, Goyal A, Bansal P, Varacallo M. Systemic Lupus Erythematosus. 2021. Aug 11. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan.</Citation><ArticleIdList><ArticleId IdType="pubmed">30571026</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson SL, Schmajuk G, Jafri K, Yazdany J, Katz P. Obesity is independently associated with worse patient-reported outcome in women with systemic lupus erythematosus. Arthritis Care Res. 2019;71(1):126&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6222022</ArticleId><ArticleId IdType="pubmed">29740985</ArticleId></ArticleIdList></Reference><Reference><Citation>Meza-Meza MR, Vizmanos-Lamotte B, Mu&#xf1;oz-Vale JF, Parra-Rojas I, Garaulet M, Montoya-Buelna M, et al.. Relationship of excess weight with clinical activity and dietary intake deficiencies in systemic lupus erythematosus patients. 2019;11(11):2683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6893805</ArticleId><ArticleId IdType="pubmed">31698711</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos-L&#xf3;pez B, Meza-Meza MR, Parra-Rojas I, Ruiz-Ballesteros AI, Vizmanos-Lamotte B, Mu&#xf1;oz-Valle F, et al.. Association of cardiometabolic risk status with clinical activity and damage in systemic lupus erythematosus patients: A cross-sectional study. Clin Immunol. 2021;222:108637. doi: 10.1016/j.clim.2020.108637</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108637</ArticleId><ArticleId IdType="pubmed">33232825</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Hazlewood GS, Kaplan GG, Eksteen B, Barnabe C. The Impact of Obesity on Remission and Disease Activity in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. AC&amp;R. 2017;69(2):157&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">27159376</ArticleId></ArticleIdList></Reference><Reference><Citation>Greuter T, Porchet F, Braga-Neto MB, Rossel JB, Biedermann L, Schreiner P, et al.. Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort. United European Gastroenterol J. 2020;8(10):1196&#x2013;1207. doi: 10.1177/2050640620954556</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2050640620954556</ArticleId><ArticleId IdType="pmc">PMC7724522</ArticleId><ArticleId IdType="pubmed">33276710</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges MC, Santos FM, Telles RW, Lanna CC, Correia MI. Nutritional status and food intake in patients with systemic lupus erythematosus. Nutrition. 2012;28(11&#x2013;12):1098&#x2013;103. doi: 10.1016/j.nut.2012.01.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2012.01.015</ArticleId><ArticleId IdType="pubmed">22898268</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al.. Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. doi: 10.1186/2046-4053-4-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al.. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. PloS Med. 2021;18(3).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8007028</ArticleId><ArticleId IdType="pubmed">33780438</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al.. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71(9):1400&#x2013;12. doi: 10.1002/art.40930</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40930</ArticleId><ArticleId IdType="pmc">PMC6827566</ArticleId><ArticleId IdType="pubmed">31385462</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO&#x2013;World Health Organization. Obesity: preventing and managing the global epidemic: report of WHO consultation on obesity. Geneva, 1998.</Citation><ArticleIdList><ArticleId IdType="pubmed">11234459</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikdashi J, Nived O. Measuring disease activity in adults with systemic lupus erythematosus: the challenges of administrative burden and responsiveness to patient concerns in clinical research. Arthritis Res Ther. 2015;17(1):1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4507322</ArticleId><ArticleId IdType="pubmed">26189728</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency. Guideline on clinical investigation of medicinal products for the treatment of systemic lupus erythematosus and lupus nephritis. 2015.</Citation></Reference><Reference><Citation>Durcan L O &#x2019;Dwyer T, Petri M. Management strategies and future directions for systemic lupus erythematosus in adults. Lancet. 2019;393:2332&#x2013;43. doi: 10.1016/S0140-6736(19)30237-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)30237-5</ArticleId><ArticleId IdType="pubmed">31180030</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M. Inflammatory markers in systemic lupus erythematosus. J Autoimmun. 2020;110:102374. doi: 10.1016/j.jaut.2019.102374</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.102374</ArticleId><ArticleId IdType="pubmed">31812331</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin R, Xu R, Ding L, Sui W, Niu M, Wang M, et al.. Circulating IL-17 Level Is Positively Associated with Disease Activity in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis. Biomed Res Int. 2021. 2021:9952463. doi: 10.1155/2021/9952463</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/9952463</ArticleId><ArticleId IdType="pmc">PMC8318742</ArticleId><ArticleId IdType="pubmed">34337065</ArticleId></ArticleIdList></Reference><Reference><Citation>W Wells GA, Shea B, O&#x2019;Connell D, Peterson J, Welch V, Losos M, et al.. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses. [Internet]
Ottawa: Ottawa Hospital Research Institute. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp</Citation></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M, Minder C. Bias in the meta-analysis was detected by a simple, graphical test. BMJ 1997;315:629&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al.. (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022).
Cochrane, 2022. Available from: www.training.cochrane.org/handbook</Citation></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 19867(3):177&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt G, Oxman AD, Akl EA, Kunz R, Brozek J, Norris S, et al.. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383&#x2013;94. doi: 10.1016/j.jclinepi.2010.04.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.04.026</ArticleId><ArticleId IdType="pubmed">21195583</ArticleId></ArticleIdList></Reference><Reference><Citation>Weijers JM, M&#xfc;skens WD, Riel PLCMV. Effect of significant weight loss on disease activity to implement this non-pharmaceutical intervention in daily clinical practice. RMD Open. 2021(7):e001498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7843325</ArticleId><ArticleId IdType="pubmed">33504577</ArticleId></ArticleIdList></Reference><Reference><Citation>Goessler KF, Gualano B, Nonino CB, Bonf&#xe1; E, Nicoletti, CF. Lifestyle interventions and weight management in systemic lupus erythematosus patients: A systematic literature review and metanalysis. J Lifestyle Med. 2022;12(1):37&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8918379</ArticleId><ArticleId IdType="pubmed">35300036</ArticleId></ArticleIdList></Reference><Reference><Citation>Kono M, Nagafuchi Y, Shoda H, Fujio K. The Impact of Obesity and a High-Fat Diet on Clinical and Immunological Features in Systemic Lupus Erythematosus. Nutrients. 2021;13(2):504. doi: 10.3390/nu13020504</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13020504</ArticleId><ArticleId IdType="pmc">PMC7913625</ArticleId><ArticleId IdType="pubmed">33557015</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YH, Song GG. Association between circulating leptin levels and systemiclupus erythematosus: an updated meta-analysis. Lupus. 2018;27(3):428&#x2013;435. doi: 10.1177/0961203317725587</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203317725587</ArticleId><ArticleId IdType="pubmed">28795654</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutens L, Stienstra R. Adipose tissue macrophages: going off track during obesity. Diabetologia. 2016;59(5):879&#x2013;94. doi: 10.1007/s00125-016-3904-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-016-3904-9</ArticleId><ArticleId IdType="pmc">PMC4826424</ArticleId><ArticleId IdType="pubmed">26940592</ArticleId></ArticleIdList></Reference><Reference><Citation>Klingberg E, Bilberg A, Bj&#xf6;rkman S, Hedberg M, Jacobsson L, Forsblad-d&#x2019;Elia H, et al.. Weight loss improves disease activity in patients with psoriatic arthritis and obesity: an interventional study. Arthritis Res Ther. 2019;21(1):17. doi: 10.1186/s13075-019-1810-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-019-1810-5</ArticleId><ArticleId IdType="pmc">PMC6330463</ArticleId><ArticleId IdType="pubmed">30635024</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupoli R, Pizzicato P, Scalera A, Ambrosino P, Amato M, Peluso R, et al.. Impact of body weight on the achievement of minimal disease activity in patients with rheumatic diseases: a systematic review and meta-analysis. Arthritis Res Ther. 2016;18(1):297. doi: 10.1186/s13075-016-1194-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-016-1194-8</ArticleId><ArticleId IdType="pmc">PMC5155390</ArticleId><ArticleId IdType="pubmed">27964760</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>